What is InterMed?
Operating as a physician-owned entity, InterMed distinguishes itself through a patient-centric model that integrates primary care with a wide array of specialty and ancillary services. The company provides critical support systems including anti-coagulation management, audiology, advanced laboratory testing, and diagnostic imaging. By housing these therapeutic services—such as physical therapy—under one organizational umbrella, InterMed optimizes the patient experience and streamlines clinical workflows. This integrated approach has solidified its reputation as a cornerstone of the Maine healthcare ecosystem, allowing for high-quality, coordinated care delivery that meets the complex needs of its patient population.
How much funding has InterMed raised?
InterMed has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in InterMed
PPP
Public-Private Partnership
What's next for InterMed?
With the successful acquisition of this major enterprise-level funding, InterMed is well-positioned to accelerate its strategic initiatives. The organization is expected to leverage this capital to enhance its diagnostic capabilities and potentially scale its therapeutic service offerings. As the healthcare sector continues to shift toward value-based care models, InterMed's focus on operational efficiency and service integration will likely serve as a catalyst for further market expansion. The firm remains focused on maintaining its physician-led governance while investing in the technological and clinical infrastructure necessary to sustain long-term growth and improve patient outcomes in an evolving regulatory environment.
See full InterMed company page
